Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine

John A. Reynolds(Manchester Academic Health Science Centre), Caroline Gordon(University of Birmingham), Munther A. Khamashta(The King's College), Ian N Bruce(University of Manchester), V. Toescu(University of Birmingham), Neil McHugh(University of Bath), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Lee‐Suan Teh(Blackburn College), Mohammed Akil, F. Leone, Mary Gayed(University Hospitals Birmingham NHS Foundation Trust), Ian Giles(University College Hospital)
Lara D. Veeken
June 29, 2022
10.1093/rheumatology/keac372
Cited by 20

Related Papers

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k